Comparative Cardiovascular Outcomes Across PCSK9-Targeted Therapies: A Real-World Matched Cohort Analysis of Inclisiran, Alirocumab, and Evolocumab (AHA 2026) - Sep 5, 2026 - Abstract #Su4079; Pres time: Nov 8, 2026; 03:15 PM - 04:15 PM; Location: Basic Science Zone, Science and Technology Hall, South Hall, Level 3; "Abstract is embargoed at this time."
Clinical • Real-world • Real-world evidence • Cardiovascular
|
|
Alex Iorfida, Saint Louis Univ Sch of Med, Saint Louis, MO; Yesh Dhruva, SLU Sch of Med, Sugar Land, TX; Nicholas Mootz, Saint Louis Univ, Saint Louis, MO; Rohit Ponnada, Saint Louis Univ SOM, El Dorado Hills, CA; Chien-Jung Lin, Saint Louis Univ- SSM SLUCARE, Saint Louis, MO
|